Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Juan Lopez

Urology Orlando, FL Medical Doctor

NPI 1275561219 CMS profile 329797

1616 Woodward St, 2B Urology, Orlando, FL 32803

Open in the dashboard

General payments

$907

26 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$58,925 paid to institutions, not to them · program years 2019–2020

Through program year 2024, Juan Lopez of Orlando, FL is reported in the CMS Open Payments database as having received $907 across 26 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $58,925 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 30th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $103 2
2022 General $165 2
2019 General $639 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Juan Lopez
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Juan Lopez were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Juan Lopez Urology median Middle half National median
2019 $639 $480 $147–$1,201 $163
2020 $0 $246 $87–$645 $114
2021 $0 $358 $111–$1,000 $132
2022 $165 $476 $143–$1,263 $149
2023 $0 $560 $168–$1,461 $160
2024 $103 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Boston Scientific Corporation $200 4 payments
  2. Astellas Pharma US Inc $193 9 payments
  3. PROCEPT BioRobotics Corporation $191 2 payments
  4. Genzyme Corporation $100 1 payment
  5. Janssen Biotech, Inc. $73 2 payments
  6. Dendreon Pharmaceuticals LLC $38 2 payments
  7. Philips Electronics North America Corporation $38 1 payment
  8. Pfizer Inc. $37 2 payments
  9. DENTSPLY IH Inc. $35 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $907 26 payments
Products named General payments · program years 2019–2024
  1. AQUABEAM ROBOTIC SYSTEM $191 2 payments
  2. MYRBETRIQ $114 8 payments
  3. JEVTANA $100 1 payment
  4. XTANDI $93 2 payments
  5. REZUM $76 2 payments
  6. ERLEADA $73 2 payments
  7. rezum Generator $65 1 payment
  8. GENERAL KIDNEY STONE DISEASE $59 1 payment
  9. PROVENGE $38 2 payments
  10. Trilogy 100 $38 1 payment
  11. Other $59 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record